HOME > Business Wire > Article


Jan. 13, 2021 16:00 UTC

Asahi Kasei to Build a Second Plant for Ceolus™ Microcrystalline Cellulose

TOKYO--(BUSINESS WIRE)-- Asahi Kasei's Specialty Solutions SBU will build a second plant for microcrystalline cellulose [1] (trade name Ceolus™) at its Mizushima Works in Kurashiki, Okayama, Japan.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210113005028/en/

Product Features (Graphic: Business Wire)

Product Features (Graphic: Business Wire)

Asahi Kasei currently manufactures Ceolus™, a microcrystalline cellulose used primarily in pharmaceuticals as tablet binder [2], in Nobeoka, Miyazaki, Japan.

Besides the standard-type product PH series, Ceolus™ has a lineup of KG series that greatly enhances the compactibility of tablets, and UF series that combines compactibility and flowability. These products provide solutions to a wide range of issues in the production of tablets for pharmaceuticals and supplements.

By using the KG series, tablets can be produced stably even when the amount of tablet binder that can be added is small, such as when tablets contain a large amount of active pharmaceutical ingredient (API) or when multiple APIs are formulated in a single tablet.

The UF series realizes stable production of tablets as well as the uniformity of contained API in tablets, which depend on the excellent flowability of the product.

In recent years, demand for proprietary KG and UF series products has increased, and further growth in demand is expected in the future. To meet such growing demand, Asahi Kasei has decided to make a capital expenditure to double the production capacity and achieve a stable supply through multiple production sites. This expansion will enable Asahi Kasei to meet the needs of the pharmaceutical and supplement industries and to contribute to life and living for people around the world.

[1] Microcrystalline cellulose is a white powder made from natural pulp, mainly used as an excipient for pharmaceuticals and foods

[2] Tablet binders are additives used for the purpose of providing the shape and increasing the volume of solid tablets

Capital Expenditure

Location:

Asahi Kasei Corporation Mizushima Works

 

Kurashiki City, Okayama Prefecture, Japan

Construction schedule:

Groundbreaking in September 2021

 

Completion in Spring 2023

Investment amount:

¥13 billion ($126 million at ¥103/$)

Product:

Ceolus™ microcrystalline cellulose

 

Contacts

Noriyoshi Shimakata
General Manager
Ceolus Overseas Sales & Marketing Department
Email: shimakata.nb@om.asahi-kasei.co.jp


Source: Asahi Kasei

Smart Multimedia Gallery

Photo

Product Features (Graphic: Business Wire)

Photo

Product and Package (Graphic: Business Wire)

Logo

View this news release and multimedia online at:
http://www.businesswire.com/news/home/20210113005028/en


The content of this press release is provided by Business Wire. If you
have any questions regarding the content, please contact the person(s)
identified in the CONTACTS box at the bottom of the release.

Business Wire


Aomori Tourism Information

HEADLINES

POLITICS
US Rejects China's Claims in South China Sea: Secretary of State Blinken
ECONOMY
Toyota Becomes World's Top-Selling Automaker in 2020 for 1st Time in 5 Years
SPORTS
Pro Baseball: Tanaka to Return to Rakuten after Pitching for Yankees for 7 Yrs
OTHER
Tokyo Daily Coronavirus Count More than Halves to 1,066 in 3 Weeks

Aomori Tourism Information

AFP-JIJI PRESS NEWS JOURNAL


Photos

Page Top